Jazz Phase III Success With Xywav In Idiopathic Hypersomnia Strengthens A Valuable Franchise

 
• By Jessica Merrill

The company plans to file for approval in the expanded indication, for which there are currently no approved therapies.

pretty woman waking up and yawning
Jazz is building out its sleep disorder franchise • Source: Shutterstock

More from Strategy

More from Business